CVE-2023-29052

Exploitation

Assessed, none found. CISA's assessment recorded neither public exploit code nor evidence of exploitation when it was made.

SSVC decision

• ExploitationnoneCISA recorded no public exploit code and no evidence of exploitation.
• AutomatablenoAt least one step from reconnaissance to exploitation cannot be reliably automated.
• Technical ImpactpartialSuccessful exploitation gives limited control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

0.44% probability of exploitation activity in the next 30 days.

EPSS percentile

Ranks above 36.2% of scored records. A rank, not a probability.

NVD base score

5.4 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

NVD analysis status

Modified. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2024-01-08 09:04Z2 YR AGO

Last updated

2025-11-04 18:14Z10 MO AGO

Reserved

2023-03-30

Assigning CNA

OX

Record state

PUBLISHED

Severity

Medium (CVSS 5.4)

CNA CVSS vector

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Weaknesses

• CWE-79Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')Base

Data version

5.2

Document digest

dab4c8adc7f2c89174547801a335709dc6bea4c06c867fb11b7c006166f68b1d

• software.open-xchange.comhttps://software.open-xchange.com/products/appsuite/doc/Release_Notes_for_Patch_Release_6251_7.10.6_2023-09-25.pdfrelease-notes
• documentation.open-xchange.comhttps://documentation.open-xchange.com/appsuite/security/advisories/csaf/2023/oxas-adv-2023-0006.jsonvendor-advisory
• seclists.orghttp://seclists.org/fulldisclosure/2024/Jan/4